[HTML][HTML] Beta-blockers and cancer: where are we?

R Peixoto, ML Pereira, M Oliveira - Pharmaceuticals, 2020‏ - mdpi.com
Cancer is one of the leading causes of death worldwide. After diagnosis, cancer treatment
may involve radiotherapy, chemotherapy, and surgery. Several of the approaches used to …

Missed therapeutic and prevention opportunities in women with BRCA‐mutated epithelial ovarian cancer and their families due to low referral rates for genetic …

PJ Hoskins, WH Gotlieb - CA: a cancer journal for clinicians, 2017‏ - Wiley Online Library
Answer questions and earn CME/CNE Fifteen percent of women with epithelial ovarian
cancer have inherited mutations in the BRCA breast cancer susceptibility genes. Knowledge …

[HTML][HTML] Personalized risk assessment for prevention and early detection of breast cancer: integration and implementation (PERSPECTIVE I&I)

JD Brooks, H Nabi, IL Andrulis, AC Antoniou… - Journal of personalized …, 2021‏ - mdpi.com
Early detection of breast cancer through screening reduces breast cancer mortality. The
benefits of screening must also be considered within the context of potential harms (eg, false …

The economic burden of cancer in Canada from a societal perspective

R Garaszczuk, JHE Yong, Z Sun, C de Oliveira - Current Oncology, 2022‏ - mdpi.com
Cancer patients and their families experience considerable financial hardship; however, the
current published literature on the economic burden of cancer at the population level has …

The economic burden of cancer care in Canada: a population-based cost study

C de Oliveira, S Weir, J Rangrej, MD Krahn… - … Open Access Journal, 2018‏ - cmajopen.ca
Background: Resource and cost issues are a growing concern in health care. Thus, it is
important to have an accurate estimate of the economic burden of care. Previous work has …

Cost-effectiveness analysis of frontline polatuzumab-rituximab, cyclophosphamide, doxorubicin, and prednisone and/or second-line chimeric antigen receptor T-cell …

A Vijenthira, J Kuruvilla, M Crump, M Jain… - Journal of Clinical …, 2023‏ - ascopubs.org
PURPOSE Recent studies of polatuzumab vedotin and CD19 chimeric antigen receptor T-
cell therapy (CAR-T) have shown significant improvements in progression-free survival over …

Do certified cancer centers provide more cost‐effective care? A health economic analysis of colon cancer care in Germany using administrative data

CY Cheng, T Datzmann, D Hernandez… - … journal of cancer, 2021‏ - Wiley Online Library
Hospital certification has become an important measure to improve cancer care quality, with
the potential effect of prolonging patient survival and reducing medical spending. However …

Cohort profile: the Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort

A Smith, D Howell, S Crouch, D Painter… - International Journal …, 2018‏ - academic.oup.com
With diverse aetiologies, treatment pathways and outcomes, haematological malignancies
comprise a heterogeneous group of over 60 cancers. 1, 2 Critically for epidemiology …

Cost-utility analysis of geriatric assessment and management in older adults with cancer: economic evaluation within 5C trial

Y Sahakyan, Q Li, SMH Alibhai, M Puts… - Journal of Clinical …, 2024‏ - ascopubs.org
PURPOSE Geriatric assessment (GA) is a guideline-recommended approach to optimize
cancer management in older adults. We conducted a cost-utility analysis alongside the 5C …

Phase-specific and lifetime costs of multiple myeloma among older adults in the US

K Bhattacharya, JP Bentley… - JAMA Network …, 2021‏ - jamanetwork.com
Importance Health care costs associated with diagnosis and care among older adults with
multiple myeloma (MM) are substantial, with cost of care and the factors involved differing …